Why Wisdom...
Why Wisdom
Ingrid Kockum, Professor of Genetic Epidemiology with focus on Multiple Sclerosis, Department of Clinical Neurosciences, Karolinska Institutet, Sweden
"I am coordinating the WISDOM project as we currently have the opportunity to use the advances in computational methods and our large multimodal data to build models that in future will help to reduce time to diagnosis and lead to predict disease outcome which may be useful in choosing treatments. In the long run I hope this will lead to better quality of life for patients and reduced costs for society."
Why Wisdom
Jordi Rambla, EGA Team Lead at CRG (Centre de Regulació Genòmica), Barcelona
“In WISDOM, we contribute the expertise of the European Genome-phenome Archive (EGA) in managing large-scale, sensitive human genomics data. We also enhance multiple sclerosis data discoverability through tools such as Beacon, and support the development of the project’s security framework.”
Why Wisdom
Mette Hartlev, Professor, PhD, LL.D, Faculty of Law, Welma, University of Copenhagen
“I am extremely inspired and motivated by WISDOM’s multi-disciplinary research design and dedicated team. As a scholar with a background in law, human rights, and ethics it is a privilege to contribute to a highly technological project where the patients are both the center of attention, and partners to the project. The combination of cutting-edge science, social and ethical perspectives and stakeholder inclusion provides a unique opportunity for advancing a research frontier which can have real impact for both patients, science, and societies. “
Why Wisdom
Narsis A. Kiani, Algorithmic Dynamics Lab Leader, Department of Oncology-Pathology, Karolinska Institutet, and CEO of YouHealth, Sweden
What excites me about WISDOM is the opportunity to shape the kind of AI and computational models needed for complex, heterogeneous, and dynamic immune-mediated diseases. From the academic side, we are interested in models that connect different layers of disease and move beyond forecasting towards a more mechanistic understanding of how disease evolves. From the YH side, we are building connected digital tools across the whole chain, from data collection and clinical studies, through research and model development, to clinical decision support. WISDOM brings these pieces together with the data, expertise, infrastructure, and legal and ethical perspectives needed to connect them. That is what makes the project particularly valuable and gives us a real opportunity to contribute to improved outcomes and a more sustainable, evidence-driven and proactive healthcare system.
Why Wisdom
Uffe Kock Wiil, Professor in Health Informatics and Technology, University of Southern Denmark
”I am excited about the opportunity that we have in WISDOM to use our group’s competences in development and implementation of AI-based models and clinical decision support systems to support shared decision making in relation to Multiple Sclerosis. I am convinced that our interdisciplinary approach involving the excellent European collaborators in WISDOM will result in novel tools to the benefit of patients and clinical experts. This is what drives me.”